Eric Salazar, MD
Anatomic Pathology & Clinical Pathology · Houston, TXNPI 1861751133
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $498 of the $596 with a category attached, or 83.6%. Werfen USA LLC accounts for 65.7% of it on its own, with 10 other manufacturers making up the rest. 2025 is the largest year on record at $408, 2.6 times the $159 reported in 2019.
Across 13 payments — averaging $45.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Werfen USA LLC$391
- Abiomed$53
- Agios Pharmaceuticals, Inc.$29
- Bristol Myers Squibb$22
- Abbott$17
- Rigel Pharmaceuticals, Inc.$16
- plus $67 from 5 others
Across 22 payments — averaging $55,656 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$907K
- Diagnostica Stago, Inc$318K
What the payments were for
- Travel & lodging$9816%
- Food & beverage$49884%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Werfen USA LLC | 2 | $391 |
| Abiomed | 1 | $53 |
| Agios Pharmaceuticals, Inc. | 2 | $29 |
| Bristol Myers Squibb | 1 | $22 |
| Abbott | 1 | $17 |
| Rigel Pharmaceuticals, Inc. | 1 | $16 |
| AstraZeneca | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
| Medtronic | 1 | $14 |
| Array Biopharma Inc | 1 | $13 |
| Incyte Corporation | 1 | $11 |
How this compares
$596 in reported general payments places this provider in the 85th percentile of 736 anatomic pathology & clinical pathology providers in Texas.
See all anatomic pathology & clinical pathology providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other anatomic pathology & clinical pathology in Houston
- Rabia ShafiHouston$519K
- Jason GregorioHouston$238K
- Sanam LoghaviHouston$94K
- Savitri KrishnamurthyHouston$80K
- Thomas LohmannHouston$30K
- Aysegul SahinHouston$29K
- Lillian GaberHouston$23K
- Ken YoungHouston$23K
- Hong ZhangHouston$22K
- Michelle WilliamsHouston$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.